أعرض تسجيلة المادة بشكل مبسط
| dc.creator |
Pinto LM |
|
| dc.creator |
Menzies D |
|
| dc.date |
2011 |
|
| dc.date.accessioned |
2013-05-30T12:58:55Z |
|
| dc.date.available |
2013-05-30T12:58:55Z |
|
| dc.date.issued |
2013-05-30 |
|
| dc.identifier |
http://www.dovepress.com/treatment-of-drug-resistant-tuberculosis-a7922 |
|
| dc.identifier |
http://www.doaj.org/doaj?func=openurl&genre=article&issn=11786973&date=2011&volume=2011&issue=default&spage=129 |
|
| dc.identifier.uri |
http://koha.mediu.edu.my:8181/jspui/handle/123456789/5527 |
|
| dc.description |
Lancelot Pinto1,2, Dick Menzies1,21Respiratory Epidemiology and Clinical Research Unit, Montreal Chest Institute, Montreal, QC, Canada; 2Department of Epidemiology and Biostatistics, McGill University, Montreal, QC, CanadaClinical question: What is the best approach to the treatment of drug-resistant tuberculosis (TB)?Results: Evidence-based treatment of drug-susceptible TB is the best means of preventing the development of drug-resistant disease. Suspecting the possibility of drug-resistant TB, and prompt detection of all forms of drug-resistant TB, not only multidrug-resistant and extensively drug-resistant TB, should be part of the algorithm for diagnosis and management of all patients with active TB.Implementation: Treatment of all forms of drug-resistant TB must be tailored to the specific form of resistance with appropriate and effective drug regimens.Keywords: drug-resistant tuberculosis, MDR-TB, treatment |
|
| dc.language |
eng |
|
| dc.publisher |
Dove Press |
|
| dc.source |
Infection and Drug Resistance |
|
| dc.title |
Treatment of drug-resistant tuberculosis |
|
الملفات في هذه المادة
|
لا توجد أي ملفات مرتبطة بهذه المادة.
|
هذه المادة تبدو في المجموعات التالية:
أعرض تسجيلة المادة بشكل مبسط